Innovating Works

STREMBLE

A stranger
MYELOMA-RISK: Personalized prognosis in smoldering myeloma through automated analysis of mutational signatures STREMBLE VENTURES LTD participó en un HORIZON EUROPE: ERC-2023-POC Multiple myeloma (MM) is the second most common haematological cancer which is symptomless until the later stages, with few treatment option...
2023-06-29 - 2024-12-31 | financed
CARDIOCARE: AN INTERDISCIPLINARY APPROACH FOR THE MANAGEMENT OF THE ELDERLY MULTIMORBID PATIENT WITH BREAST CANC... STREMBLE VENTURES LTD participó en un H2020: H2020-SC1-BHC-2018-2020 More than 50% of the newly diagnosed breast cancer patients are elderly and particularly susceptible to cardiotoxicity of cancer treatment d...
2021-01-22 - 2025-06-30 | financed
iBorderCtrl: Intelligent Portable Border Control System STREMBLE VENTURES LTD participó en un H2020: H2020-BES-2014-2015 ICROSS envisages to enable faster thorough border control for third country nationals crossing the borders of EU, with technologies that ado...
2016-04-19 - 2019-08-31 | financed
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.